Abstract
Recent studies have shown that IL-17 plays a role in eosinophil, macrophage and neutrophil signaling and recruitment, especially in Asthma and COPD. Therefore, the hypothesis is that inhibition of this interleukin will be able to reduce inflammation, remodeling and oxidative stress in an experimental model of ACOS, acting as a therapeutic alternative. Objectives description: to study the …